Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That is very scary. Both of my parents had debilitating and deadly autoimmune diseases. They are truly horrible. Death from Covid would be more merciful that what happened to them.
Nader said BLA’s by EOY too, and then there is the long hauler trial that is imminent too.
So depressed. How could you tell Manipples?
133k bid @$5. Strong support
Weak and incredible use of old information, name-calling is the tactic of those with no substance and persuasive for only those of low intelligence. It won’t age well.
I read it takes a year to qualify a new mfr.
There are a lot more longhaulers than S/C right? What is the value of that?
Fill up Samsung and Lonza (who they also already qualified).
May God’s Grace and wisdom strengthen and comfort her and all of your family and guide those doctors in her care. Faith in things not seen, can be strong enough to move mountains.
https://mobile.twitter.com/cmichaelgibson
Quote: “ People who recover from COVID-19 sometimes later test positive suggesting that they have a lingering infection. A study now hints instead that Covid May integrate into human DNA in some cases like HIV.”
There was a cup and handle thingy. That means it’s so hot it needs a handle to hold onto.
Decisively pierced with volume and big bid support. $4 support will likely be tested, but it seems that market forces want it to be.
So DSMB recommends unnecessary deaths in the placebo arm? Not a lot of analysis needed on mortality.
Nov 23 (75% day) + 28 days?
No need to cover those short positions brokers will do it for them.
Past 3.95 it actually looks thin all the way to 10 right now.
Cool!
Are we on the cusp of orgasmic growth?
Oh my, and then CYDY is marginable and Robin Hood able!
I love your work! Always meticulous and correct! Bustin those Bolle’s!
More like fruit fly months!
Holla FOUR DOLLAH!
Please elaborate, I do not understand what you are talking about. Which study was shortened to 14 days to cover up deaths?
Leronlimab is a completely different drug that costed more than $20 million dollars to develop as a humanized monoclonal antibody! Cytolin in not humanized. FDA would not allow it to proceed until it was, so Nader bought Leronlimab.
We should ask Janet Woodcock what, if anything that she has done since her appointment in May to bring the most effective therapeutics for use in the USA.
My last buy was at $2.41, but I sure don’t plan to sell anywhere near here.
Would appreciate something official from Cytodyn on enrollment. Someone on YMB said they were denied enrollment on Saturday because enrollment was full.
Chewing through $3.30
I hope it is cured someday. Autoimmune diseases are horrible.
No there isn’t. It’s the mother of all MAB’s. I understand a patient attempting to enroll in CD12 on Saturday was told it is full. Interesting story about Leronlimab....
https://www.bioprocessonline.com/doc/the-perilous-development-of-a-potential-biologic-blockbuster-0001
From September 2020 incelldx PR:
"We are thrilled to partner with MD Biosciences following our successful working relationship during the past year, "said Dr. Bruce Patterson, CEO of IncellDx. We are excited to offer a standardized solution to cytokine and immunology testing in partnership with MD Biosciences' CLIA certified reference laboratories in the US and Europe. We are pleased to get these solutions out prior to the approval of Cytokine Storm-related therapeutics, and in the short term, are focused on helping those COVID-19 patients still suffering symptoms long after diagnosis—so called long-haulers. To that effort, we will be establishing a COVID-19 long-hauler diagnosis and treatment initiative involving a multi-disciplinary approach to improving the lives of those suffering long-term symptoms."
The deal with MD Biosciences also includes receptor occupancy assays for CCR5 directed therapeutics, a promising target in the fight against COVID-19 and possibly other "cytokine storm" related conditions.
Excellent article, this could actually be a much bigger market and benefit to mankind than any of us realize not just for Covid long-haulers. I’m excited to see our study done!
Great analysis! Very well done!
I sure hope so, it is overdue.